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A B S T R A C T
Brucellosis, Q fever and melioidosis are zoonoses, which can lead to pyrexia. These diseases are often under-
ascertained and underreported because of their unspeciﬁc clinical signs and symptoms, insuﬃcient awareness by
physicians and public health oﬃcers and limited diagnostic capabilities, especially in low-resource countries.
Therefore, the presence of Brucella spp., Coxiella burnetii and Burkholderia pseudomallei was investigated in
Malagasy patients exhibiting febrile illness. In addition, we analyzed zebu cattle and their ticks as potential
reservoirs for Brucella and C. burnetii, respectively. Speciﬁc quantitative real-time PCR assays (qPCRs) were
performed on 1020 blood samples drawn from febrile patients. In total, 15 samples (1.5%) were Brucella-
positive, mainly originating from patients without travel history, while DNA from C. burnetii and Bu. pseudomallei
was not detected.
Anti-C. burnetii antibodies were found in four out of 201 zebu serum samples (2%), whereas anti-Brucella
antibodies could not be detected. Brucella DNA was detected in a single zebu sample. Three out of 330 ticks
analyzed (1%) were positively tested for C. burnetii DNA but with high Ct values in the qPCR assay. Our data
suggest that zebus as well as Amblyomma and Boophilus ticks have to be considered as a natural reservoir or
vector for C. burnetii, but the risk of cattle-to-human transmission is low. Since bovine brucellosis does not seem
to contribute to human infections in Madagascar, other transmission routes have to be assumed.
1. Introduction
Brucella spp., Coxiella burnetii and Burkholderia pseudomallei are
Gram-negative pathogens, which cause brucellosis, Q fever, and
melioidosis, respectively. They may considerably aﬀect human and
animal health, especially in low-resource areas. While Q fever and
brucellosis are classical zoonotic diseases, melioidosis is a saprozoono-
sis, indicating that the source of infection is the abiotic environment
(e.g. contaminated soil or water) (Hubalek, 2003). In areas endemic for
malaria and typhoid fever, zoonotic infections, often characterised by
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non-speciﬁc clinical symptoms such as fever, headache, and fatigue, are
underdiagnosed (Crump et al., 2013; Halliday et al., 2015). Hence,
physicians should be aware of zoonotic diseases as a cause of fever of
unknown origin (FUO) (Cleri et al., 2007).
Worldwide, more than 500,000 human brucellosis cases are re-
ported annually, with high incidences in the Middle East and Central
Asia (e.g. Syria, Iran, Iraq, Mongolia, Kirgizstan) and North Africa (e.g.
Algeria) (Pappas et al., 2006). Human disease is mainly caused by Br.
melitensis, Br. abortus and Br. suis which are transmitted to humans
through direct contact with infected livestock (i.e. sheep, goat, cattle,
pig), their excretions (faeces, urine, placenta and aborts) or by ingestion
of contaminated food products (mainly unpasteurized dairy products
and raw meat). In livestock farming, brucellosis leads to tremendous
economic losses due to decreased milk production, abortions and
limited fertility (McDermott and Arimi, 2002).
With the exception of New Zealand and French Polynesia, Q fever
has a worldwide distribution (Million and Raoult, 2015). The largest Q
fever outbreak so far has been notiﬁed in the Netherlands with more
than 4000 human cases between 2007 and 2010 (Schneeberger et al.,
2014). According to a recent review covering 51 studies, Q fever
seroprevalence in the general African population is less than 8% with
slightly higher rates in children (10–17%). However, it varies widely
among geographic regions and a much higher seroprevalence was
found in Egypt (32%) (Vanderburg et al., 2014). The main reservoirs of
C. burnetii are mammals and arthropods, with ruminants (sheep, goat,
cattle) as the most common source of human infections. The disease is
usually transmitted through inhalation of aerosols from amniotic ﬂuid
or placenta material of infected animals, although ingestion, transfu-
sion and sexual intercourse may sporadically occur (Million and Raoult,
2015). Acute, chronic (endocarditis) or subclinical courses have been
described after infection with C. burnetii. In livestock, Q fever can lead
to a loss of productivity mostly due to increased abortion rates
(Vanderburg et al., 2014).
Melioidosis is a tropical disease, which is predominantly reported in
Southeast Asia (i.e. Thailand, Singapore, Vietnam, Malaysia) and North
Australia, although sporadic cases also occur elsewhere. In a recent
study on the global burden of melioidosis, a total of 165,000 cases
including 89,000 fatalities per year were estimated worldwide. These
estimates were associated with substantial uncertainty
(Limmathurotsakul et al., 2016). The reported number of cases in
tropical low-resource countries are likely to be underestimated due to
insuﬃcient disease awareness and absence of diagnostic facilities
(Hoﬀmaster et al., 2015). The host species spectrum of Bu. pseudomallei
is broad including pigs, sheep, goats, horses, dogs and cats. A wide
range of clinical symptoms have been described in humans, e.g. fever,
headaches, muscle pain, pneumonia with chest pain and cough,
abscesses. Humans are infected through contact with contaminated
surface water and mud or indirectly through the inhalation of con-
taminated aerosols (Heymann, 2008).
Madagascar is a large island situated in the Indian Ocean, 500 km
east of Mozambique, with an area of 587,295 km2. The island is divided
into 22 regions with a total population of 23,400,000 (INSTAT, 2016).
Its climate is tropical along the coast, temperate in the Central High-
lands and arid in the South. Livestock is mainly composed of cattle (ca.
10 million), goats (ca. 1,470,000), sheep (ca. 840,000) and pigs (ca.
1,500,000) (Data 2012: FAOSTAT (2015)). Recent epidemiological data
on the presence of brucellosis (McDermott and Arimi, 2002) and Q
fever (Vanderburg et al., 2014) in Madagascar do not exist and only
sporadic cases of melioidosis have been reported (Garin et al., 2014).
Therefore, our objective was to investigate the presence of C.
burnetii, Brucella and Bu. pseudomallei in Malagasy patients suﬀering
from febrile illness as a potential sentinel symptom for zoonotic
diseases. Furthermore, we aimed to identify potential sources of human
infections, by screening zebus for Brucella and both zebus and ticks for
C. burnetii.
2. Materials and methods
2.1. Human study population and survey area
The International Vaccine Institute (IVI) collected blood samples
within the Typhoid Fever Surveillance in Africa Program (TSAP). This
network aims to generate data on the burden of typhoid fever and other
invasive Salmonella infections through standardized surveillance and
disease burden studies in ten African countries (von Kalckreuth et al.,
2016).
The TSAP survey sites in Madagascar consisted of public health care
facilities in central Madagascar, both in a rural environment
(Imerintsiatosika) and urban slums (Isotry, located in the capital of
Madagascar Antananarivo) with a catchment population of 46,000 and
70,000 inhabitants, respectively. In the rural catchment area, cattle
husbandry and rice farming are predominant and the people live in
close contact with their animals. In total, 18% and 9% of the population
in Imerintsiatosika and Isotry sought care for fever in the surveillance
facilities (Panzner et al., 2016). A total of 4500 whole blood EDTA
samples were collected in Madagascar between 2011 and 2013 within
the framework of TSAP from patients with unknown diagnosis at
presentation and a body temperature ≥37.5 °C. From these, a subset
of 1020 samples taken from patients with pyrexia ≥38.5 °C was
screened for C. burnetii, Brucella spp. and Bu. pseudomallei. The selection
of the subset was motivated in anticipation of a greater chance to detect
bacteraemia in patients with a higher body temperature. However, we
cannot exclude that in the samples not analyzed (≥37.5 °C and<
38.5 °C) we might have missed subclinical or chronic infections.
Samples were stored at −20 °C prior to testing. Demographic data
(age, gender), place of residence, travel history, clinical signs and
symptoms as well as medication use were recorded.
Informed written consent was obtained from the patients, their
parents or their legal guardians. The study was approved by the
Malagasy Ethical Committee (no. 045 MSANP/CE) and the IVI
Institutional Review Board (no. IVI IRB #2011-001).
2.2. Sampling of zebu and ticks
In October 2012, a total of 215 zebu cattle were sampled in three
slaughterhouses in the municipality of Bemasoandro (district of
Antananarivo-Atsimondrano). Origin of the cattle, age, sex, health
and nutritional status were recorded.
Both whole blood and serum samples were taken, 214 samples could
be used for bacteriology and qPCR, and 201 samples for serology.
In total, 1822 ticks (1090 Amblyomma variegatum and 732
Rhipicephalus (Boophilus) microplus were collected with a maximum of
10 ticks sampled from each cattle as described previously by Keller
et al. (2016). A random sample of 330 ticks (including 199 Amblyomma
variegatum and 131 Rhipicephalus microplus ticks) from 80 cattle was
used for screening.
2.3. Molecular and serological tests
2.3.1. DNA preparation from blood samples and ticks
Genomic DNA was prepared from 1 ml of human EDTA blood
samples using the FlexiGene DNA Kit (Qiagen, Hilden, Germany). For
zebu blood samples either FlexiGene DNA Kits (Qiagen) or High Pure
Template Preparation Kits (Roche Diagnostics GmbH, Mannheim,
Germany) were used. After mechanical disruption DNA was extracted
from ticks by the QIAamp DNA Mini Kit (Qiagen) as previously
described (Keller et al., 2016).
2.3.2. Brucella spp. detection
Quantitative real-time PCR assays (qPCR) were performed to detect
brucellae in human and zebu samples by targeting the genus speciﬁc
marker sequences bcsp31 and IS711 (Al Dahouk et al., 2007; Cloeckaert
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et al., 2000). The IS711 qPCR is supposed to be speciﬁc and highly
sensitive for the detection of the genus Brucella, with an analytical
sensitivity of 2 fg (Bounaadja et al., 2009). Speciﬁcity and sensitivity of
the bcsp31 qPCR are also known to be high, but its limit of detection
ranges between 16 and 18 fg (Al Dahouk et al., 2007). For qPCR, the
Quantifast Pathogen Detection Kit (Qiagen, Hilden, Germany) with an
internal ampliﬁcation control was used. Each DNA sample was ana-
lyzed in duplicate against positive and negative matrix controls
according to the MIQE guidelines (Bustin et al., 2010). A sample was
considered Brucella-positive if the genus speciﬁc IS711 qPCR showed a
positive test result. The result was conﬁrmed by the qPCR targeting
bcsp31. A threshold cycle value (Ct) > 40 was deemed to be false
positive and considered negative.
Zebu serum samples were screened for anti-Brucella antibodies using
ELISA (IDEXX Brucellosis Serum X2 Ab Test; IDEXX, Hoofddorp, the
Netherlands), serum agglutination test and complement ﬁxation test
(Pourquier, IDEXX, Hoofddorp, the Netherlands) according to manu-
facturers’ instructions. Furthermore, whole blood samples were trans-
ferred to a selective biphasic culture medium (Brodie and Sinton, 1975;
Corner et al., 1985; Ruiz Castaneda, 1961), incubated at 37 °C with and
without 10% CO2 (Alton et al., 1975) and potential growth of bacteria
was monitored weekly on the solid phase of the culture ﬂasks. Growing
bacteria were identiﬁed by MALDI-TOF MS (Karger et al., 2013). If no
colonies were observed, the ﬂasks were shaken and further incubated.
In the absence of growth, samples were ﬁnally declared negative after
six weeks.
2.3.3. Coxiella burnetii and Bu. pseudomallei detection
To detect C. burnetii in human and tick samples, speciﬁc and highly
sensitive qPCRs targeting IS1111 were used (Klee et al., 2006). For the
detection of Bu. pseudomallei in human samples, we carried out qPCRs
targeting ﬂiC (Tomaso et al., 2005; Tomaso et al., 2004).
We also tested for C. burnetii Phase I/II IgG antibodies in zebu serum
samples by a commercially available ELISA (IDEXX Q Fever Ab Test;
IDEXX Switzerland AG, Liebefeld-Bern, Switzerland) according to the
manufacturer’s guidelines (with S/P deﬁned as the ratio between
optical density (OD) of the sample (S) and OD of the positive control
(P), S/P≥ 40% was considered positive, results in the interval
Fig. 1. Brucellosis cases in febrile patients originating from the regions Analamanga (A) and Itasy (B), Madagascar, 2011–2013. Diagnosis was based on the detection of Brucella-speciﬁc
target sequences in human blood samples, both IS711 and bcsp31 (n = 7, red squares) or solely IS711 (n = 8, yellow square). A single IS711-positive zebu (yellow circle) was detected in
the Tsiroanomadidy district (Bongolava region) in 2012. The Red Cross represents the sampling sites in Antananarivo (basic health centre CSB II Isotry and clinic CHU Tsaralalana) and in
Itasy (basic health centre CSB II Imerintsiatosika).
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30%≤ S/P < 40% were considered to be doubtful and S/P < 30%
was interpreted as negative). The values of test accuracy provided by
the manufacturer (personal communication) were 0.93 for sensitivity and
1.0 for speciﬁcity. However, the test has never been validated in zebus.
2.4. Statistical analysis
The proportion of positive samples and respective 95% conﬁdence
intervals (95% CI) were determined assuming a binomial distribution.
Fisher’s exact test and Wilcoxon rank sum test were used to compare
categorical data and continuous non-normal data, respectively. We
calculated odds ratios (OR) with 95% CIs to describe the strength of
associations between the infection status and independent variables. P-
values < 0.05 were considered signiﬁcant. Statistical analysis was
performed using STATA 13.1 (StataCorp, TX, USA).
3. Results
3.1. Characteristics of the study population
Patients presented to the children’s ward (n = 29; 3%), inpatient
(n = 3) or outpatient departments (n = 988; 97%) of two basic health
centres (CSB II Isotry, Antananarivo, Analamanga region (n = 627;
61%); CSB II Imerintsiatosika, Itasy region (n = 389; 38%)) and one
clinic (CHU Tsaralalana, Antananarivo (n = 4)) from September 2011
to May 2013. The district of residence was known for 1011 out of 1020
febrile patients. In total, 626 (61.4%) patients originated from the
central region of Analamanga (620 patients from the urban district of
Antananarivo-Renivohitra, the country’s capital, and six patients from
the bordering districts Atsimondrano, Ambohidratrimo and
Avaradrano). A total of 385 (37.7%) patients were residents of the
Arivonimamo district in the central region of Itasy. The median age of
the patients (n = 1020) was 21 years (range 0–79, IQR 11; 34), and 611
(60%) were females. Their body temperature ranged from 38.5 to 41 °C
(median 39 °C, IQR 38.6; 39.2). The date of onset of symptomatic
febrile illness is shown in Fig. 2. The patients mainly suﬀered from
clinical symptoms of ﬂu-like or gastrointestinal disease (Table 1). Most
of them were treated symptomatically with nonsteroidal anti-inﬂam-
matory drugs and less than 20% received causal treatment on spec (i.e.
antibiotics or antimalarial medication).
3.2. Prevalence of Brucella, C. burnetii, Bu. pseudomallei in febrile patients
The Brucella-speciﬁc molecular marker IS711 was detected in 15
samples (1.5%, 95% CI [0.8–2.4]). Of these, seven samples were
conﬁrmed by the detection of bcsp31. The Brucella-positive samples
were obtained from eight females and seven males, aged 7–65 years
(median 24), who were recruited in the outpatient department of the
CSB II Imerintsiatosika. All cases were residents of rural villages in the
district of Arivonimamo (Itasy region) (Fig. 1, Table 1). Thirteen cases
felt ill from 21st September through 26th December 2011, and two
cases from 28th August through 3rd September 2012 (Fig. 2). There
were no signiﬁcant associations between human brucellosis and age
(p = 0.25; Wilcoxon rank sum test) or gender (p = 0.60; Fisher’s exact
test) of the cases (Table 1). Brucellosis cases presented less frequently
with a cough (13% vs. 55%; OR 0.14, 95% CI [0.01-0.57]) or headaches
(53% vs. 81%; OR 0.26, 95% CI [0.08-0.86]) than other febrile patients.
In contrast, brucellosis cases were more likely to suﬀer from arthralgia
(27% vs. 3%; OR 12.7, 95% CI [2.8-46.0]) than non-brucellosis febrile
patients (Table 1).
Only a single case travelled outside of her local residence 7 days
before the onset of the current illness.
Neither C. burnetii nor Bu. pseudomallei DNA was detected in the
investigated human blood samples.
3.3. Prevalence of Brucella and C. burnetii in zebus and ticks
All zebus were male (213/215, while two zebus lacked information
on sex), aged between 4 and 20 years (median: 8 years) and three
animals were clinically identiﬁed to be sick. The zebus originated from
the regions Bongolava (n = 83), Haute Matsiatra (n = 66), Menabe
(n = 31), Soﬁa (n = 23), Vakinankaratra (n = 11) and Itasy (n = 1).
Brucella DNA (IS711-marker) was detected in a single eight years old
healthy zebu (0.5%, 95% CI [0.01-2.6]) originating from the Bongolava
region. Brucellosis could not be serologically or microbiologically
veriﬁed.
Anti-C. burnetii antibodies were detected in four out of 201 available
serum samples of adequate quality (2%, 95% CI [0.5–5.0]), all
originating from zebus aged seven to eight years old, of the
Bongolava region (Fig. 3). In addition, six samples suspected to be
positive, originated from Vakinankaratra (2), Menabe (2), Haute
Matsiatra (1) and Bongolava (1) (Fig. 3).
Three out of 330 ticks analyzed (1%), including two Amblyomma
variegatum and one Rhipicephalus microplus, were positively tested for C.
burnetii DNA but with high Ct values (39.1, 39.9, 41.4) in the qPCR
assays.
4. Discussion
To the best of our knowledge, this survey represents the ﬁrst
evidence of human brucellosis in febrile patients in Madagascar.
Indeed, a single seropositive case had been reported in 1982, but the
Fig. 2. Date of onset of symptomatic disease in febrile patients, Madagascar, September 2011-May 2013 (n = 1006; 14 patients without symptom onset information are not represented).
Brucella IS711 positive patients are marked in black (n = 15).
I. Boone et al. Acta Tropica 172 (2017) 255–262
258
source of infection could not be clariﬁed and whether it was an
autochthonous case remained doubtful (Ribot and Coulanges, 1982).
All brucellosis cases identiﬁed in our study lived in rural villages of
the district Arivonimamo, suggesting an endemic cluster or an out-
break. In contrast, no cases were detected among patients resident in
the country’s capital. Despite the considerable sample size, the catch-
ment area only covered central regions of Madagascar and may
therefore not be representative for the whole country.
As the incubation period may extend to several months (Heymann,
2008), travel-associated infections cannot be ruled out but only one
case had a recent travel history. In 13 cases, the reported disease onset
spanned three months (September-December 2011), while in two cases
the symptoms occurred within one week (end of August-beginning of
September 2012). Since data for backtracking are missing, we do not
know whether these cases were epidemiologically linked, whether they
were in contact with infected animals or associated with abortions in
ruminants or whether they had consumed contaminated animal pro-
ducts (non-pasteurized dairy products or undercooked/raw meat).
In our study, brucellosis cases were more likely to suﬀer from
arthralgia than febrile patients without brucellosis. Although clinical
symptoms of human brucellosis are not pathognomonic, arthralgia is
frequently described (in 65% of the cases, 95% CI [58–72]), according
to a meta-analysis by Dean et al. (2012). In contrast, the number of
cases suﬀering from arthralgia was quite low in the present study
(27%), but in line with studies from India (24%) and Kuwait (21%)
(Mantur et al., 2006; Mousa et al., 1988). The phenomenon that
coughing is less likely among cases compared to other febrile patients
was already observed in a study on human brucellosis in Tanzania
(Bouley et al., 2012). As Brucella DNA can persist for years after clinical
cure and in the absence of symptoms indicative of disease persistence or
relapse, our study population may have comprised acute, chronic or
even asymptomatic brucellosis cases with fever of hitherto unknown
origin (Vrioni et al., 2008). Eight IS711-positive samples could not be
conﬁrmed using the bcsp31 qPCR which can be explained by the high
copy number of IS711 resulting in a higher sensitivity, whereas bcsp31
only exists in a single copy in the Brucella genome.
All zebu samples were seronegative and except for a single case
(IS711 positive, but bcsp31 negative) Brucella DNA could not be found.
The detection of Brucella in only one animal among 201 seronegative
zebus from various ﬂocks might be explained by a spill-over of a non-
host speciﬁc Brucella species, such as Br. melitensis from sheep or goats,
and a low infection pressure or a spill-over from wildlife. So far, only Br.
suis biovar 5 has been isolated, from a bitch in 1973 (Verger et al.,
1975), and there is no further evidence of the occurrence of brucellosis
on the island.
Malagasy zebus, which compose 80% of the cattle population
(Meyer, 2016), are related to East African shorthorn zebus on the
African mainland (Decker et al., 2014). According to oﬃcial data from
FAOSTAT (2015), livestock animals are rarely imported. Since the
1990s a total of 2870 heads of cattle have been imported from New
Zealand (in 2005/2006), which is oﬃcially free from bovine brucello-
sis, and 52 sheep and nine pigs have been imported from France
(FAOSTAT, 2015). In addition, four goats were imported from Comoros
in 2007, followed by 208,300 goats imported from Australia in 2008.
However, the real volume of livestock trade in Madagascar might be
underestimated in the FAO database.
Brucellosis is highly prevalent in neighbouring Tanzania (3.5-10%
seroprevalence in humans, 21.5–48% seroprevalence in dairy cattle)
(Bouley et al., 2012; Mathew et al., 2015; Shirima et al., 2014) and in
Mozambique, where a seroprevalence of 27% was detected in buﬀaloes
(Tanner et al., 2015). In contrast, on the nearby island of Mauritius, Br.
abortus was isolated just once from a foetus aborted by a cow in 1947
and human brucellosis was only suspected to occur (Webb and
Webb,1948). According to our data, zebus do not seem to play a role
in the transmission of Brucella spp. in Madagascar, which suggests that
other reservoir species may be involved (i.e. small ruminants, pigs,
wildlife or pets). In Madagascar, cattle farming is mostly concentrated
in the north-western, the western coast and the southern part of the
island, whereas 85% of goat and sheep farms are located in the South,
and pig rearing is mainly found in central Madagascar (MAEP, 2007).
Due to the rather isolated geographical location of Madagascar, we
hypothesize humans could have been infected by other potentially
endemic Brucella spp. distinct from Br. abortus.
Although human samples were not found to be C. burnetii-positive, a
seropositivity of 2% was detected in zebus, which suggests a low risk for
the Malagasy population to acquire Q fever. False positive serological
test results cannot be excluded but C. burnetii DNA was detected in
ticks, indicating that the bacterium is actually present on the island. In
Madagascar, only a few human Q fever cases were reported in the ﬁfties
and sixties (Courdurier et al., 1952; Guiot and Lemaigre, 1964). The
Table 1
Demographics and clinical features of febrile patients with (n = 15) and without (n = 1005) Brucella infection, deﬁned by molecular detection of IS711, Madagascar, 2011–2013.
Brucellosis cases (N = 15) Febrile patients without brucellosis (N = 1005)
n/N (%) n/N (%) P value OR [95% CI]
Demographics
Male sex 7/15 (46.7) 402/1005 (40.0) 0.61 1.31 [0.40–4.18]
Age (years): median (IQR) 24 (14; 35) 21 (11; 34) 0.25
Rural 15/15 (100) 370/996 (37.2) < 0.001* Undeﬁned
Clinical symptoms and signs
Median body temperature (°C) on admission (IQR) 39 (38.5; 39.7) 38.9 (38.6; 39.2) 0.46
Diarrhea 4/15 (26.7) 221/1005 (22.0) 0.75 1.29 [0.30–4.41]
Headache 8/15 (53.3) 817/1005 (81.3) 0.01* 0.26 [0.08–0.86]
Constipation 0/15 (0) 23/1005 (2.29) 0.55 0 [0.00–11.20]
Sore throat 3/15 (20) 353/1005 (35.1) 0.28 0.46 [0.08–1.73]
Rash 0/15 (0) 14/1005 (1.39) 1.00 Undeﬁned
Cough 2/15 (13.3) 549/1005 (54.6) 0.003* 0.14 [0.01–0.57]
Vomiting 3/15 (20) 231/1005 (23) 1.00 0.84 [0.15–3.14]
Arthralgia 4/15 (26.7) 28/1005 (2.8) < 0.001* 12.69 [2.75–45.99]
Hospital admission 0/15 (0) 6/995 (0.6) 1.00 Undeﬁned
Use of medication prior to consultation
Analgesics 7/15 (46.7) 393/836 (47.0) 1.00 0.99 [0.30–3.14]
Antibiotics 2/15 (13.3) 171/770 (22.2) 0.54 0.54 [0.06–2.42]
Antimalaria 0/13 (0) 19/675 (2.8) 1.00 Undeﬁned
OR: odds ratio, CI: conﬁdence interval, IQR: interquartile range.
* P < 0.05.
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Fig. 3. Regions of origin of the sampled zebus, Madagascar, 2012 (in diﬀerent grey scales). C. burnetii seropositive zebu cattle (green squares, n = 4), suspected positive zebu cases
(yellow squares, n = 6), qPCR-positive ticks (red triangle).
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ﬁrst clinical case conﬁrmed by serology was described in 1959 (Porte
et al., 1959). In 1964, a Q fever outbreak aﬀected 30 patients suﬀering
from a typhoid-like syndrome and atypical pneumonia (Guiot and
Lemaigre, 1964). On neighbouring islands of Madagascar, C. burnetii
was detected in humans (Artagnan et al., 2008) and ruminants in
Reunion (Cardinale et al., 2014). In 1992, a seroprevalence of 5.4% was
reported in healthy blood donors from the Comoros (Dupont et al.,
1995) and in 2012, a case of Q fever was diagnosed in a patient
returning from the same archipelago (Brouqui et al., 2005). The
seroprevalence in cattle in Madagascar (2%) was lower than in
neighbouring Reunion (11.8%) (Cardinale et al., 2014) and on main-
land Africa, where the C. burnetii seroprevalence ranged between 4% in
Senegal and 32% in Cameroon (Vanderburg et al., 2014). However,
seroprevalence comparisons should be interpreted with caution due to
diﬀerences in the sampling design, sample size and diagnostic tests
used. In the present study, only male zebus were sampled which may
not be the population with the highest C. burnetii seroprevalence in
Madagascar. In Denmark for instance, a signiﬁcantly higher seropreva-
lence was observed among dairy cattle compared to beef breeds, and in
females compared to males (Paul et al., 2014).
No evidence for Bu. pseudomallei was found among the febrile
patients investigated. A recent study predicted an annual melioidosis
incidence of 880 cases (95% credible interval [326–2464]) per 100,000
population in Madagascar suggesting that the disease is considerably
underreported. There are large diﬀerences in environmental suitability
for Bu. pseudomallei persistence on the island (Limmathurotsakul et al.,
2016). Central Madagascar where our sampling sites were located,
revealed a lower predicted environmental suitability for Bu. pseudo-
mallei, which might explain the absence of clinical cases in the
catchment area. In 1936, Bu. pseudomallei had already been isolated
from a pig in Madagascar (Girard, 1936) and later also from soil
samples collected on the island (Galimand and Dodin, 1982). Auto-
chthonous human cases of melioidosis have recently been reported
(Garin et al., 2014) as well as cases in travellers returning from
Madagascar (Borgherini et al., 2006; Ezzedine et al., 2007). From time
to time sporadic cases are notiﬁed in the Indian Ocean region
(Borgherini et al., 2015; Issack et al., 2005).
As the qPCR assays used did not allow for Brucella spp. diﬀerentia-
tion and the role of reservoir animals (other than zebu) could not be
assessed, further studies both in humans (especially in high risk groups
such as farmers, shepherds, butchers, food factory workers, veterinar-
ians) and in animals (including other ruminants and wildlife) are
required in Madagascar, and should be complimented by Brucella
species identiﬁcation and genotyping to establish possible geographic
and evolutionary associations. To fully appraise the burden of brucel-
losis and Q fever in Madagascar, future sampling strategies should
include regions where livestock production (cattle, sheep/goat, and
pig) is concentrated, as well as wildlife. The current study suggests an
underdiagnosis of brucellosis cases in Madagascar, which may be
explained by a lack of disease awareness due to unspeciﬁc clinical
signs and symptoms. Hence, specialised laboratory facilities have to be
established for future surveillance. It should be evaluated whether
syndromic surveillance of abortions among ruminants can contribute to
the early identiﬁcation of Brucella spp. of public health importance and
possible Q fever cases. With respect to Bu. pseudomallei, environmental
samples (e.g. from rice paddy ﬁelds) are currently investigated.
In summary, based on the current study and literature data, there is
suﬃcient evidence for the occurrence of Brucella spp., C. burnettii and
Bu. pseudomallei on the island of Madagascar. Whether the virulence of
the pathogens, the genetic background of animal hosts or climate
conditions contribute to the low number of human cases remains to be
investigated. Nevertheless, brucellosis, Q fever and melioidosis have to
be taken into account in the diﬀerential diagnosis of febrile illnesses
both in Malagasy patients and in travellers returning from Madagascar.
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